Horizons Series: TPMT and NUDT15 Genotyping Recommendations


 TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus 

  • This content was reviewed no later than 3 years post-recording; CPC determined it was still useful and relevant; an update was recommended. 
  • Revised and/or updated educational content is anticipated with the release of the associated guideline / manuscript update.
  • Content is scheduled for review at 6 years post-recording.

Please note that in the time since this material was published, there may have been additional developments, advancements, and/or more current publications in this field. Please contact AMPClinicalPractice@amp.org with questions or concerns.


This contains the webinar recording
Continuing education credit is no longer available for this webinar

Description:

In this pre-recorded lecture, AMP Pharmacogenomics Working Group members Dr. Reynold Ly moderates as Dr. Makenzie Fulmer provides an update on clinical TPMT and NUDT15 testing, which was recently published online by the JMD. With a goal of promoting standardization of clinical PGx testing across different clinical laboratories, this Working Group has published recommendations on CYP2C19, CYP2C9, Warfarin allele and CYP2D6 genotyping allele selections previously, and now TPMT and NUDT15 selection for clinical laboratories to use as guidelines when designing and developing these PGx assays. Healthcare providers may also find these documents useful in comparing and contrasting PGx tests across clinical laboratories when they are familiar with a “must-test” list for each of the pharmacogenes. Access Practice Guideline here.

Learning Objectives:
    • Review TPMT and NUDT15 pharmacogenetics (PGx) and highlight the importance of standardization of clinical PGx and its implications to patient care
    • Review the AMP PGx Working Group ‘Tier’ system of PGx sequence variants/alleles recommendation
    • Explain the key attributes of Tier 1 and Tier 2 recommended alleles for TPMT and NUDT15 genotyping




Speaker:
Makenzie L. Fulmer, PhD

Department of Pathology and ARUP Laboratories
University of Utah School of Medicine

Moderator:
Reynold C. Ly, PhD

Indiana University School of Medicine, 
Department of Medical and Molecular Genetics


Duration: 1 Hour
Level of Instruction: Intermediate
Date Recorded: August 30, 2022

Planned and coordinated by the Training and Education Committee

Continuing Education Credit Information

Continuing education credit is no longer available for this webinar

 


Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.